Rebecca C. Northeast
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rebecca C. Northeast has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- David A. Bechtold
Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
4 shared publications - Leanne Hodson
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
3 shared publications - Ann Louise Hunter
The University of Manchester; Faculty of Biology, Medicine and Health; Centre for Biological Timing
2 shared publications - David William Ray
NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
2 shared publications - Nichola J. Barron
Blond McIndoe Laboratories, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty Biology, Medicine and Health, University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK
2 shared publications - Polly Downton
University of Manchester
2 shared publications
Latest Publications
- Open Access
The adaptor protein DAB2 cell-autonomously links APOE with disease-associated microglia (DAM)/TREM2 state dysregulation associated with Alzheimer’s disease
The neuron-secreted Reelin (RELN) protein and its adaptor DAB1 modify Alzheimer’s disease (AD) risk through genetic interaction with APOE4. While RELN and APOE4 exert antagonistic effects on amyloid and Tau pathology in mice, how risk is conferred in the human brain remains unclear. The related adaptor DAB2 endocytoses RELN/APOE receptors and, via LRP8, modulates non-canonical pro-inflammatory signalling in non-neuronal cells. We hypothesised that RELN and APOE signalling directly influence microglial function to modify AD risk. Integrating human brain transcriptomics, a Reln -deficient mouse, and DAB1/DAB2 knock-down in APOE isogenic iPSC-microglia, we found that microglial DAB1/DAB2 pathways were dynamically regulated across the lifespan, with DAB2 dysregulated with increasing amyloid pathology. DAB2 transcriptional networks correlated with disease- and lipid-associated microglial states (DAM/LDAM) linked to networks expressing dementia-risk loci (TREM2, GRN, ACE, SORL1) and associated with endolysosomal and lipid-handling pathways. DAB2-knockdown cell-autonomously shifted microglia away from gene networks enriched in DAM/TREM2 states and towards pro-inflammatory cytokine-responsive states and TNFα-NFκB pathways. APOE4/E4 microglia showed elevated APOE and reduced DAB1pY232 under inflammatory stress, and blunted DAB2-knockdown transcriptomic responses, consistent with pathway-level genetic interaction. In vivo, RELN-deficiency reduced microglial ramification and increased CD68. These findings identify DAB2 as a regulator of microglial state transitions and a modifier of dementia-risk networks linking APOE genotype to inflammatory, phagocytic and amyloid-beta clearance pathways relevant to AD. The microglial endocytic DAB2 adaptor links APOE and RELN genetic risk pathways in the human brain and is dysregulated with increasing amyloid pathology in Alzheimer’s Disease DAB2 cell-autonomously sustains iPSC-microglial disease-associated DAM/TREM2 activated states which are associated with dementia-risk loci Loss of DAB2 shifts APOE iPSC-microglia away from protective DAM/TREM2 states and towards pro-inflammatory cytokine-responsive states DAB2 knockdown inflammatory/senescent responses are attenuated in an APOE4/E4 background suggesting genetic interaction at the pathway level
Open AccessThe adaptor protein DAB2 cell-autonomously links APOE with disease-associated microglia (DAM)/TREM2 state dysregulation associated with Alzheimer’s disease
The neuron-secreted Reelin (RELN) protein and its adaptor DAB1 modify Alzheimer’s disease (AD) risk through genetic interaction with APOE4. While RELN and APOE4 exert antagonistic effects on amyloid and Tau pathology in mice, how risk is conferred in the human brain remains unclear. The related adaptor DAB2 endocytoses RELN/APOE receptors and, via LRP8, modulates non-canonical pro-inflammatory signalling in non-neuronal cells. We hypothesised that RELN and APOE signalling directly influence microglial function to modify AD risk. Integrating human brain transcriptomics, a Reln -deficient mouse, and DAB1/DAB2 knock-down in APOE isogenic iPSC-microglia, we found that microglial DAB1/DAB2 pathways were dynamically regulated across the lifespan, with DAB2 dysregulated with increasing amyloid pathology. DAB2 transcriptional networks correlated with disease- and lipid-associated microglial states (DAM/LDAM) linked to networks expressing dementia-risk loci (TREM2, GRN, ACE, SORL1) and associated with endolysosomal and lipid-handling pathways. DAB2-knockdown cell-autonomously shifted microglia away from gene networks enriched in DAM/TREM2 states and towards pro-inflammatory cytokine-responsive states and TNFα-NFκB pathways. APOE4/E4 microglia showed elevated APOE and reduced DAB1pY232 under inflammatory stress, and blunted DAB2-knockdown transcriptomic responses, consistent with pathway-level genetic interaction. In vivo, RELN-deficiency reduced microglial ramification and increased CD68. These findings identify DAB2 as a regulator of microglial state transitions and a modifier of dementia-risk networks linking APOE genotype to inflammatory, phagocytic and amyloid-beta clearance pathways relevant to AD. The microglial endocytic DAB2 adaptor links APOE and RELN genetic risk pathways in the human brain and is dysregulated with increasing amyloid pathology in Alzheimer’s Disease DAB2 cell-autonomously sustains iPSC-microglial disease-associated DAM/TREM2 activated states which are associated with dementia-risk loci Loss of DAB2 shifts APOE iPSC-microglia away from protective DAM/TREM2 states and towards pro-inflammatory cytokine-responsive states DAB2 knockdown inflammatory/senescent responses are attenuated in an APOE4/E4 background suggesting genetic interaction at the pathway level
- Open Access
Ribosomal modification by BUD23 drives selective translational control over energy state and metabolic health
Summary: Efficient energy metabolism is essential for health and its dysregulation drives cardiometabolic disease. Delivery of regulatory control through translation and ribosome function is emerging as important. Here, we identify the rRNA methyltransferase BUD23 as a potent regulator of cellular and systemic energy homeostasis. Adipocyte-specific deletion of BUD23 in mice regulates lipid and mitochondrial metabolism resulting in a pronounced lean phenotype and resistance to diet-induced obesity. Mechanistically, BUD23 modulates translation initiation and efficiency of mRNAs with specific features – including short 5’ UTR length and GC-rich post-initiation codon usage – characteristic of mitochondrial and lipogenic proteins. Genetic analyses and Mendelian randomisation support a role for BUD23 in human cardiometabolic traits and disease burden. Together, our findings uncover a conserved translational control mechanism that regulates energy state, from cellular metabolism through to human cardiometabolic health.
Open AccessRibosomal modification by BUD23 drives selective translational control over energy state and metabolic health
Summary: Efficient energy metabolism is essential for health and its dysregulation drives cardiometabolic disease. Delivery of regulatory control through translation and ribosome function is emerging as important. Here, we identify the rRNA methyltransferase BUD23 as a potent regulator of cellular and systemic energy homeostasis. Adipocyte-specific deletion of BUD23 in mice regulates lipid and mitochondrial metabolism resulting in a pronounced lean phenotype and resistance to diet-induced obesity. Mechanistically, BUD23 modulates translation initiation and efficiency of mRNAs with specific features – including short 5’ UTR length and GC-rich post-initiation codon usage – characteristic of mitochondrial and lipogenic proteins. Genetic analyses and Mendelian randomisation support a role for BUD23 in human cardiometabolic traits and disease burden. Together, our findings uncover a conserved translational control mechanism that regulates energy state, from cellular metabolism through to human cardiometabolic health.
- Open Access
- 5 August 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Adipocyte NR1D1 dictates adipose tissue expansion during obesity
The circadian clock component NR1D1 (REVERBα) is considered a dominant regulator of lipid metabolism, with global Nr1d1 deletion driving dysregulation of white adipose tissue (WAT) lipogenesis and obesity. However, a similar phenotype is not observed under adipocyte-selective deletion (Nr1d1Flox2-6:AdipoqCre), and transcriptional profiling demonstrates that, under basal conditions, direct targets of NR1D1 regulation are limited, and include the circadian clock and collagen dynamics. Under high-fat diet (HFD) feeding, Nr1d1Flox2-6:AdipoqCre mice do manifest profound obesity, yet without the accompanying WAT inflammation and fibrosis exhibited by controls. Integration of the WAT NR1D1 cistrome with differential gene expression reveals broad control of metabolic processes by NR1D1 which is unmasked in the obese state. Adipocyte NR1D1 does not drive an anticipatory daily rhythm in WAT lipogenesis, but rather modulates WAT activity in response to alterations in metabolic state. Importantly, NR1D1 action in adipocytes is critical to the development of obesity-related WAT pathology and insulin resistance.
- 5 August 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Open AccessAdipocyte NR1D1 dictates adipose tissue expansion during obesity
The circadian clock component NR1D1 (REVERBα) is considered a dominant regulator of lipid metabolism, with global Nr1d1 deletion driving dysregulation of white adipose tissue (WAT) lipogenesis and obesity. However, a similar phenotype is not observed under adipocyte-selective deletion (Nr1d1Flox2-6:AdipoqCre), and transcriptional profiling demonstrates that, under basal conditions, direct targets of NR1D1 regulation are limited, and include the circadian clock and collagen dynamics. Under high-fat diet (HFD) feeding, Nr1d1Flox2-6:AdipoqCre mice do manifest profound obesity, yet without the accompanying WAT inflammation and fibrosis exhibited by controls. Integration of the WAT NR1D1 cistrome with differential gene expression reveals broad control of metabolic processes by NR1D1 which is unmasked in the obese state. Adipocyte NR1D1 does not drive an anticipatory daily rhythm in WAT lipogenesis, but rather modulates WAT activity in response to alterations in metabolic state. Importantly, NR1D1 action in adipocytes is critical to the development of obesity-related WAT pathology and insulin resistance.
- Open Access
Adipocyte REVERBα dictates adipose tissue expansion during obesity
The circadian clock component REVERBα is considered a dominant regulator of lipid metabolism, with global Reverbα deletion driving dysregulation of white adipose tissue (WAT) lipogenesis and obesity. However, a similar phenotype is not observed under adipocyte-selective deletion ( Reverbα Flox2-6 Adipo Cre ), and transcriptional profiling demonstrates that, under basal conditions, direct targets of REVERBα regulation are limited, and include the circadian clock and collagen dynamics. Under high-fat diet (HFD) feeding, Reverbα Flox2-6 Adipo Cre mice do manifest profound obesity, yet without the accompanying WAT inflammation and fibrosis exhibited by controls. Integration of the WAT REVERBα cistrome with differential gene expression reveals broad control of metabolic processes by REVERBα which is unmasked in the obese state. Adipocyte REVERBα does not drive an anticipatory daily rhythm in WAT lipogenesis, but rather modulates WAT activity in response to alterations in metabolic state. Importantly, REVERBα action in adipocytes is critical to the development of obesity-related WAT pathology and insulin resistance.
Open AccessAdipocyte REVERBα dictates adipose tissue expansion during obesity
The circadian clock component REVERBα is considered a dominant regulator of lipid metabolism, with global Reverbα deletion driving dysregulation of white adipose tissue (WAT) lipogenesis and obesity. However, a similar phenotype is not observed under adipocyte-selective deletion ( Reverbα Flox2-6 Adipo Cre ), and transcriptional profiling demonstrates that, under basal conditions, direct targets of REVERBα regulation are limited, and include the circadian clock and collagen dynamics. Under high-fat diet (HFD) feeding, Reverbα Flox2-6 Adipo Cre mice do manifest profound obesity, yet without the accompanying WAT inflammation and fibrosis exhibited by controls. Integration of the WAT REVERBα cistrome with differential gene expression reveals broad control of metabolic processes by REVERBα which is unmasked in the obese state. Adipocyte REVERBα does not drive an anticipatory daily rhythm in WAT lipogenesis, but rather modulates WAT activity in response to alterations in metabolic state. Importantly, REVERBα action in adipocytes is critical to the development of obesity-related WAT pathology and insulin resistance.
- Open Access
- 1 June 2020
- Published by Elsevier in Current Opinion in Physiology
- Vol. 15, 183-191
Eat, sleep, repeat: the role of the circadian system in balancing sleep–wake control with metabolic need
- 1 June 2020
- Published by Elsevier in Current Opinion in Physiology
- Vol. 15, 183-191
Open AccessEat, sleep, repeat: the role of the circadian system in balancing sleep–wake control with metabolic need
- Open Access
- 22 July 2019
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 42 (11)
Sleep homeostasis during daytime food entrainment in mice
Twenty-four hour rhythms of physiology and behavior are driven by the environment and an internal endogenous timing system. Daily restricted feeding (RF) in nocturnal rodents during their inactive phase initiates food anticipatory activity (FAA) and a reorganization of the typical 24-hour sleep–wake structure. Here, we investigate the effects of daytime feeding, where food access was restricted to 4 hours during the light period ZT4-8 (Zeitgeber time; ZT0 is lights on), on sleep–wake architecture and sleep homeostasis in mice. Following 10 days of RF, mice were returned to ad libitum feeding. To mimic the spontaneous wakefulness associated with FAA and daytime feeding, mice were then sleep deprived between ZT3-6. Although the amount of wake increased during FAA and subsequent feeding, total wake time over 24 hours remained stable as the loss of sleep in the light phase was compensated for by an increase in sleep in the dark phase. Interestingly, sleep that followed spontaneous wake episodes during the dark period and the extended period of wake associated with FAA, exhibited lower levels of slow-wave activity (SWA) when compared to baseline or after sleep deprivation, despite a similar duration of waking. This suggests an evolutionary mechanism of reducing sleep drive during negative energy balance to enable greater arousal for food-seeking behaviors. However, the total amount of sleep and SWA accumulated during the 24 hours was similar between baseline and RF. In summary, our study suggests that despite substantial changes in the daily distribution and quality of wake induced by RF, sleep homeostasis is maintained.
- 22 July 2019
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 42 (11)
Open AccessSleep homeostasis during daytime food entrainment in mice
Twenty-four hour rhythms of physiology and behavior are driven by the environment and an internal endogenous timing system. Daily restricted feeding (RF) in nocturnal rodents during their inactive phase initiates food anticipatory activity (FAA) and a reorganization of the typical 24-hour sleep–wake structure. Here, we investigate the effects of daytime feeding, where food access was restricted to 4 hours during the light period ZT4-8 (Zeitgeber time; ZT0 is lights on), on sleep–wake architecture and sleep homeostasis in mice. Following 10 days of RF, mice were returned to ad libitum feeding. To mimic the spontaneous wakefulness associated with FAA and daytime feeding, mice were then sleep deprived between ZT3-6. Although the amount of wake increased during FAA and subsequent feeding, total wake time over 24 hours remained stable as the loss of sleep in the light phase was compensated for by an increase in sleep in the dark phase. Interestingly, sleep that followed spontaneous wake episodes during the dark period and the extended period of wake associated with FAA, exhibited lower levels of slow-wave activity (SWA) when compared to baseline or after sleep deprivation, despite a similar duration of waking. This suggests an evolutionary mechanism of reducing sleep drive during negative energy balance to enable greater arousal for food-seeking behaviors. However, the total amount of sleep and SWA accumulated during the 24 hours was similar between baseline and RF. In summary, our study suggests that despite substantial changes in the daily distribution and quality of wake induced by RF, sleep homeostasis is maintained.